EAU 2024: Bladder cancer latest

Share :
Published: 9 Apr 2024
Views: 2988
Dr Bernadett Szabados, Dr Félix Guerrero-Ramos, Dr Yohann Loriot, Prof Andrea Necchi and Dr Cosimo De Nunzio

Dr Bernadett Szabados (University College London Hospital, London, UK), Dr Yohann Loriot (Gustave Roussy, Paris, France), Prof Andrea Necchi (The Vita-Salute San Raffaele University, Milan, Italy), Dr Cosimo De Nunzio (Sant'Andrea Hospital, University La Sapienza, Rome, Italy) and Dr Felix Guerrero-Ramos (Hospital Universitario 12 de Octubre, Madrid, Spain) discuss bladder cancer highlights from EAU 2024.

The experts focused on the results of the CheckMate 274 and IMvigor011 phase III trials, as discussed by Dr Loriot and Prof Necchi.

They also talked about treatment options for patients in the bacillus Calmette–Guérin (BCG) refractory setting, as well as the data from the SunRISe-1 and BladderGATE trials.

This programme is supported by an unrestricted educational grant from Janssen.